Literature DB >> 18805650

Breast cancer regional radiation fields for supraclavicular and axillary lymph node treatment: is a posterior axillary boost field technique optimal?

Xiaochun Wang1, Tse Kuan Yu, Mohammad Salehpour, Sean X Zhang, Tzouh Liang Sun, Thomas A Buchholz.   

Abstract

PURPOSE: To assess whether using an anterior oblique supraclavicular (SCV) field with a posterior axillary boost (PAB) field is an optimal technique for targeting axillary (AX) lymph nodes compared with two computed tomography (CT)-based techniques: (1) an SCV field with an anterior boost field and (2) intensity-modulated radiotherapy (IMRT). METHODS AND MATERIALS: Ten patients with CT simulation data treated with postmastectomy radiation that included an SCV field were selected for the study. Supraclavicular nodes and AX Level I-III nodes within the SCV field were contoured and defined as the treatment target. Plans using the three techniques were generated and evaluated for each patient.
RESULTS: The anterior axillary boost field and IMRT resulted in superior dose coverage compared with PAB. Namely, treatment volumes that received 105%, 80%, and 30% of prescribed dose for IMRT plans were significantly less than those for the anterior axillary boost plans, which were significantly less than PAB. For PAB and anterior axillary boost plans, there was a linear correlation between treatment volume receiving 105% of prescribed dose and maximum target depth. Furthermore, the IMRT technique resulted in better lung sparing and dose conformity to the target than anterior axillary boost, which again was significantly better than PAB. The maximum cord dose for IMRT was small, but higher than for the other two techniques. More monitor units were required to deliver the IMRT plan than the PAB plan, which was more than the anterior axillary boost plan.
CONCLUSIONS: The PAB technique is not optimal for treatment of AX lymph nodes in an SCV field. We conclude that CT treatment planning with dose optimization around delineated target volumes should become standard for radiation treatments of supraclavicular and AX lymph nodes.

Entities:  

Mesh:

Year:  2008        PMID: 18805650     DOI: 10.1016/j.ijrobp.2008.07.016

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  4 in total

1.  How do I deal with the axilla in patients with a positive sentinel lymph node?

Authors:  Conrad B Falkson
Journal:  Curr Treat Options Oncol       Date:  2011-12

2.  Caught in the middle: case study of a brachial (sentry) lymph node recurrence after resection and locoregional breast radiotherapy.

Authors:  G Lee; M Clemons; J Cho; G J Czarnota; R Dinniwell
Journal:  Curr Oncol       Date:  2012-06       Impact factor: 3.677

3.  Potential gains: Comparison of a mono-isocentric three-dimensional conformal radiotherapy (3D-CRT) planning technique to hybrid intensity-modulated radiotherapy (hIMRT) to the whole breast and supraclavicular fossa (SCF) region.

Authors:  Leigh Ambrose; Cameron Stanton; Lorraine Lewis; Gillian Lamoury; Marita Morgia; Susan Carroll; Regina Bromley; John Atyeo
Journal:  J Med Radiat Sci       Date:  2021-05-06

4.  Comprehensive nodal breast VMAT: solving the low-dose wash dilemma using an iterative knowledge-based radiotherapy planning solution.

Authors:  Cameron Stanton; Linda J Bell; Andrew Le; Brooke Griffiths; Kenny Wu; Jessica Adams; Leigh Ambrose; Denise Andree-Evarts; Brian Porter; Regina Bromley; Kirsten van Gysen; Marita Morgia; Gillian Lamoury; Thomas Eade; Jeremy T Booth; Susan Carroll
Journal:  J Med Radiat Sci       Date:  2021-08-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.